| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.851 | 0.003 | 0.851 | Vasodilator, coronary | 0.845 0.003 DBMET02975 0.457 0.022 DBMET00380 0.26 0.124 DBMET02976 | ||
| 0.85 | 0.003 | 0.868 | Vasodilator, peripheral | 0.868 0.003 DBMET02975 0.578 0.018 DBMET00380 0.338 0.079 DBMET02976 | DBMET02975 | |
| 0.808 | 0.001 | 0.808 | Calcium channel activator | 0.759 0.001 DBMET02975 0.621 0.002 DBMET00380 0.444 0.012 DBMET02976 | ||
| 0.801 | 0.003 | 0.801 | Calcium channel blocker | 0.733 0.003 DBMET02975 0.578 0.004 DBMET00380 0.169 0.045 DBMET02976 | ||
| 0.763 | 0.001 | 0.763 | Calcium antagonist | 0.675 0.001 DBMET02975 0.342 0.004 DBMET00380 | ||
| 0.751 | 0.004 | 0.751 | Vasodilator | 0.724 0.004 DBMET02975 0.447 0.016 DBMET00380 | ||
| 0.74 | 0.002 | 0.74 | Calcium channel L-type activator | 0.723 0.002 DBMET02975 0.739 0.002 DBMET00380 0.607 0.005 DBMET02976 | ||
| 0.717 | 0.002 | 0.717 | TRPA1 agonist | 0.703 0.002 DBMET02975 0.177 0.017 DBMET00380 0.126 0.051 DBMET02976 | ||
| 0.664 | 0.002 | 0.664 | Calcium channel L-type blocker | 0.66 0.002 DBMET02975 0.463 0.003 DBMET00380 0.099 0.025 DBMET02976 | ||
| 0.657 | 0.003 | 0.657 | Calcium channel (voltage-sensitive) blocker | 0.559 0.004 DBMET02975 0.402 0.004 DBMET00380 | ||
| 0.592 | 0.008 | 0.592 | Cardiotonic | 0.546 0.011 DBMET02975 0.195 0.124 DBMET00380 0.288 0.061 DBMET02976 | ||
| 0.389 | 0.005 | 0.389 | Alpha 2b adrenoreceptor antagonist | 0.245 0.015 DBMET02975 0.229 0.018 DBMET00380 | ||
| 0.458 | 0.098 | 0.56 | DNA polymerase beta inhibitor | 0.443 0.103 DBMET02975 0.56 0.069 DBMET00380 | DBMET00380 | |
| 0.35 | 0.026 | 0.366 | Cyclic AMP phosphodiesterase inhibitor | 0.366 0.022 DBMET02975 0.232 0.073 DBMET00380 0.199 0.094 DBMET02976 | DBMET02975 | |
| 0.309 | 0.006 | 0.369 | Adenylate kinase inhibitor | 0.369 0.004 DBMET02975 0.166 0.021 DBMET00380 0.22 0.013 DBMET02976 | DBMET02975 | |
| 0.353 | 0.052 | 0.353 | Spasmolytic | 0.344 0.054 DBMET02975 | ||
| 0.313 | 0.02 | 0.397 | Diuretic | 0.397 0.013 DBMET02975 | DBMET02975 | |
| 0.339 | 0.049 | 0.35 | Hypoxia-inducible factor 1 alpha inhibitor | 0.35 0.045 DBMET02975 0.27 0.083 DBMET00380 | DBMET02975 | |
| 0.316 | 0.032 | 0.316 | Platelet aggregation inhibitor | 0.265 0.046 DBMET02975 | ||
| 0.288 | 0.007 | 0.288 | Alpha 2c adrenoreceptor antagonist | 0.191 0.02 DBMET02975 0.182 0.022 DBMET00380 | ||
| 0.394 | 0.118 | 0.497 | DNA directed DNA polymerase inhibitor | 0.395 0.117 DBMET02975 0.497 0.083 DBMET00380 | DBMET00380 | |
| 0.278 | 0.003 | 0.278 | Aldosterone antagonist | 0.22 0.004 DBMET02975 0.048 0.032 DBMET00380 0.045 0.038 DBMET02976 | ||
| 0.27 | 0.005 | 0.27 | CF transmembrane conductance regulator agonist | 0.241 0.008 DBMET02975 0.152 0.072 DBMET00380 0.159 0.062 DBMET02976 | ||
| 0.269 | 0.007 | 0.269 | Neuropeptide Y1 antagonist | 0.243 0.009 DBMET02975 0.257 0.008 DBMET00380 | ||
| 0.295 | 0.033 | 0.295 | 5 Hydroxytryptamine 1E antagonist | 0.22 0.108 DBMET02975 0.234 0.092 DBMET00380 0.188 0.145 DBMET02976 | ||
| 0.288 | 0.031 | 0.288 | P-glycoprotein inhibitor | 0.244 0.043 DBMET02975 0.199 0.064 DBMET00380 | ||
| 0.361 | 0.125 | 0.437 | Transcription factor inhibitor | 0.293 0.158 DBMET02975 0.437 0.095 DBMET00380 | DBMET00380 | |
| 0.312 | 0.095 | 0.375 | Thioredoxin glutathione reductase inhibitor | 0.275 0.118 DBMET02975 0.375 0.067 DBMET00380 | DBMET00380 | |
| 0.29 | 0.081 | 0.31 | Interleukin 2 agonist | 0.31 0.067 DBMET02975 0.257 0.111 DBMET00380 0.228 0.145 DBMET02976 | DBMET02975 | |
| 0.276 | 0.069 | 0.621 | Aryl hydrocarbon receptor agonist | 0.213 0.095 DBMET02975 0.621 0.013 DBMET00380 | DBMET00380 | |
| 0.199 | 0.004 | 0.199 | Glycine receptor antagonist | 0.187 0.004 DBMET02975 0.078 0.06 DBMET00380 0.086 0.047 DBMET02976 | ||
| 0.215 | 0.023 | 0.292 | Mannose-6-phosphate isomerase inhibitor | 0.227 0.018 DBMET02975 0.292 0.006 DBMET00380 0.134 0.08 DBMET02976 | DBMET00380 | |
| 0.343 | 0.151 | 0.492 | Caspase 9 stimulant | 0.274 0.224 DBMET02975 0.492 0.063 DBMET00380 | DBMET00380 | |
| 0.284 | 0.104 | 0.306 | Transcription factor NF kappa B inhibitor | 0.306 0.091 DBMET02975 0.264 0.118 DBMET00380 0.202 0.167 DBMET02976 | DBMET02975 | |
| 0.188 | 0.015 | 0.188 | Androgen antagonist | 0.166 0.018 DBMET02975 0.1 0.047 DBMET00380 | ||
| 0.187 | 0.016 | 0.187 | Alpha 1b adrenoreceptor antagonist | 0.099 0.035 DBMET02975 | ||
| 0.176 | 0.012 | 0.176 | Alpha 1d adrenoreceptor antagonist | 0.089 0.026 DBMET02975 | ||
| 0.212 | 0.05 | 0.228 | Amyloid beta precursor protein antagonist | 0.228 0.042 DBMET02975 0.146 0.106 DBMET00380 | DBMET02975 | |
| 0.177 | 0.017 | 0.177 | Alpha 2a adrenoreceptor antagonist | 0.081 0.047 DBMET02975 | ||
| 0.198 | 0.042 | 0.203 | Interleukin 6 antagonist | 0.167 0.067 DBMET02975 0.203 0.039 DBMET00380 | DBMET00380 | |
| 0.222 | 0.072 | 0.434 | RNA-directed DNA polymerase inhibitor | 0.229 0.065 DBMET02975 0.214 0.081 DBMET00380 0.434 0.015 DBMET02976 | DBMET02976 | |
| 0.264 | 0.115 | 0.287 | Apoptosis antagonist | 0.287 0.094 DBMET02975 | DBMET02975 | |
| 0.184 | 0.039 | 0.266 | GABA C receptor rho-2 antagonist | 0.15 0.074 DBMET02975 0.241 0.014 DBMET00380 0.266 0.009 DBMET02976 | DBMET02976 | |
| 0.164 | 0.019 | 0.164 | Beta glucuronidase inhibitor | 0.161 0.02 DBMET02975 0.121 0.045 DBMET00380 0.1 0.069 DBMET02976 | ||
| 0.204 | 0.068 | 0.239 | Non-steroidal antiinflammatory agent | 0.233 0.05 DBMET02975 0.239 0.047 DBMET00380 | DBMET00380 | |
| 0.137 | 0.005 | 0.137 | Mineralocorticoid receptor antagonist | 0.122 0.006 DBMET02975 | ||
| 0.268 | 0.137 | 0.286 | Calpain 2 inhibitor | 0.286 0.123 DBMET00380 | DBMET00380 | |
| 0.219 | 0.089 | 0.258 | Platelet antagonist | 0.258 0.069 DBMET02975 | DBMET02975 | |
| 0.183 | 0.055 | 0.301 | Cytidine deaminase inhibitor | 0.172 0.061 DBMET02975 0.301 0.019 DBMET00380 | DBMET00380 | |
| 0.225 | 0.098 | 0.254 | Interleukin agonist | 0.254 0.075 DBMET02975 0.223 0.1 DBMET00380 0.217 0.105 DBMET02976 | DBMET02975 | |
| 0.148 | 0.022 | 0.178 | DOPA decarboxylase inhibitor | 0.175 0.012 DBMET02975 0.178 0.011 DBMET00380 0.144 0.025 DBMET02976 | DBMET00380 | |
| 0.135 | 0.014 | 0.135 | Adenosine A3 receptor antagonist | 0.109 0.022 DBMET02975 0.074 0.052 DBMET00380 | ||
| 0.182 | 0.068 | 0.314 | Sigma receptor agonist | 0.167 0.075 DBMET02975 0.314 0.036 DBMET00380 | DBMET00380 | |
| 0.156 | 0.046 | 0.174 | Farnesoid X receptor antagonist | 0.174 0.033 DBMET02975 | DBMET02975 | |
| 0.279 | 0.17 | 0.462 | Alpha-glucosidase inhibitor | 0.263 0.18 DBMET02975 0.462 0.092 DBMET00380 | DBMET00380 | |
| 0.24 | 0.134 | 0.3 | Antithrombotic | 0.3 0.088 DBMET02975 0.215 0.159 DBMET02976 | DBMET02975 | |
| 0.144 | 0.039 | 0.17 | Sphingosine 1-phosphate receptor 4 antagonist | 0.144 0.039 DBMET02975 0.17 0.019 DBMET00380 | DBMET00380 | |
| 0.159 | 0.057 | 0.184 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.184 0.028 DBMET02975 0.135 0.103 DBMET00380 0.163 0.051 DBMET02976 | DBMET02975 | |
| 0.126 | 0.024 | 0.126 | Interleukin 12 antagonist | 0.116 0.033 DBMET02975 0.123 0.026 DBMET00380 | ||
| 0.196 | 0.095 | 0.196 | Nitric-oxide synthase stimulant | 0.171 0.15 DBMET02975 0.193 0.101 DBMET00380 0.193 0.101 DBMET02976 | ||
| 0.252 | 0.156 | 0.311 | Beta lactamase inhibitor | 0.311 0.13 DBMET00380 | DBMET00380 | |
| 0.149 | 0.052 | 0.186 | M18 aspartyl aminopeptidase inhibitor | 0.155 0.049 DBMET02975 0.186 0.038 DBMET00380 | DBMET00380 | |
| 0.143 | 0.049 | 0.143 | Platelet activating factor antagonist | |||
| 0.168 | 0.076 | 0.194 | 3C-like protease (Human coronavirus) inhibitor | 0.146 0.107 DBMET02975 0.194 0.055 DBMET00380 0.188 0.059 DBMET02976 | DBMET00380 | |
| 0.194 | 0.104 | 0.39 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.197 0.102 DBMET02975 0.39 0.04 DBMET00380 | DBMET00380 | |
| 0.165 | 0.077 | 0.265 | Mcl-1 antagonist | 0.229 0.043 DBMET02975 0.265 0.031 DBMET00380 | DBMET00380 | |
| 0.169 | 0.081 | 0.277 | Succinate dehydrogenase inhibitor | 0.215 0.038 DBMET02975 0.188 0.059 DBMET00380 0.277 0.015 DBMET02976 | DBMET02976 | |
| 0.123 | 0.035 | 0.123 | Alpha 2 adrenoreceptor antagonist | |||
| 0.18 | 0.093 | 0.257 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.199 0.073 DBMET02975 0.212 0.063 DBMET00380 0.257 0.039 DBMET02976 | DBMET02976 | |
| 0.147 | 0.059 | 0.147 | Pregnane X receptor agonist | 0.124 0.117 DBMET02975 | ||
| 0.244 | 0.159 | 0.464 | GABA C receptor rho-3 antagonist | 0.387 0.067 DBMET00380 0.464 0.037 DBMET02976 | DBMET02976 | |
| 0.161 | 0.077 | 0.162 | Neurotensin receptor agonist | 0.162 0.076 DBMET02975 0.138 0.135 DBMET00380 0.15 0.1 DBMET02976 | DBMET02975 | |
| 0.092 | 0.011 | 0.092 | Potassium channel intermediate-conductance Ca-activated blocker | 0.068 0.029 DBMET02975 0.079 0.018 DBMET00380 | ||
| 0.097 | 0.017 | 0.097 | Calcium channel T-type blocker | |||
| 0.215 | 0.135 | 0.379 | 12-Lipoxygenase inhibitor | 0.216 0.134 DBMET02975 0.379 0.046 DBMET00380 0.232 0.121 DBMET02976 | DBMET00380 | |
| 0.128 | 0.048 | 0.134 | Photosensitizer | 0.129 0.047 DBMET02975 0.134 0.042 DBMET00380 0.129 0.047 DBMET02976 | DBMET00380 | |
| 0.133 | 0.057 | 0.208 | Alkylator | 0.125 0.063 DBMET02975 0.208 0.024 DBMET00380 0.122 0.066 DBMET02976 | DBMET00380 | |
| 0.163 | 0.088 | 0.223 | Lipocortins synthesis antagonist | 0.201 0.055 DBMET02975 0.223 0.044 DBMET02976 | DBMET02976 | |
| 0.108 | 0.034 | 0.124 | Bile acid receptor antagonist | 0.124 0.017 DBMET02975 0.094 0.062 DBMET02976 | DBMET02975 | |
| 0.115 | 0.042 | 0.217 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.183 0.019 DBMET02975 0.096 0.058 DBMET00380 0.217 0.013 DBMET02976 | DBMET02976 | |
| 0.166 | 0.098 | 0.199 | Anesthetic general | 0.166 0.098 DBMET02975 0.199 0.075 DBMET00380 | DBMET00380 | |
| 0.116 | 0.048 | 0.121 | Toll-Like receptor 4 antagonist | 0.107 0.06 DBMET02975 0.121 0.043 DBMET00380 | DBMET00380 | |
| 0.107 | 0.041 | 0.107 | Alpha 1 adrenoreceptor antagonist | |||
| 0.078 | 0.013 | 0.103 | Thromboxane synthase inhibitor | 0.103 0.006 DBMET02975 0.055 0.036 DBMET00380 0.053 0.04 DBMET02976 | DBMET02975 | |
| 0.188 | 0.124 | 0.251 | Antioxidant | 0.21 0.107 DBMET02975 0.251 0.083 DBMET02976 | DBMET02976 | |
| 0.074 | 0.01 | 0.074 | Potassium channel (Inward rectifier) activator | 0.055 0.026 DBMET02975 | ||
| 0.1 | 0.036 | 0.1 | Alpha 1a adrenoreceptor antagonist | |||
| 0.106 | 0.043 | 0.129 | ABCA1 expression enhancer | 0.129 0.025 DBMET02975 | DBMET02975 | |
| 0.139 | 0.077 | 0.146 | Heat shock protein 70 antagonist | 0.146 0.055 DBMET02975 0.135 0.097 DBMET00380 0.143 0.064 DBMET02976 | DBMET02975 | |
| 0.071 | 0.009 | 0.071 | Potassium channel (ATP-sensitive) activator | 0.052 0.026 DBMET02975 | ||
| 0.074 | 0.015 | 0.074 | Nicotinic alpha3beta2 receptor antagonist | 0.051 0.041 DBMET02975 0.057 0.031 DBMET00380 | ||
| 0.079 | 0.024 | 0.101 | Glutamate (mGluR1) antagonist | 0.072 0.028 DBMET02975 0.101 0.016 DBMET00380 0.07 0.03 DBMET02976 | DBMET00380 | |
| 0.113 | 0.058 | 0.152 | Multidrug resistance-associated protein 1 inhibitor | 0.11 0.062 DBMET02975 0.152 0.024 DBMET00380 | DBMET00380 | |
| 0.091 | 0.036 | 0.222 | Histidine decarboxylase inhibitor | 0.177 0.015 DBMET02975 0.119 0.026 DBMET00380 0.222 0.011 DBMET02976 | DBMET02976 | |
| 0.233 | 0.18 | 0.324 | 15-Lipoxygenase inhibitor | 0.324 0.115 DBMET00380 | DBMET00380 | |
| 0.141 | 0.092 | 0.165 | Interferon gamma antagonist | 0.165 0.061 DBMET02975 0.138 0.095 DBMET00380 0.164 0.062 DBMET02976 | DBMET02975 | |
| 0.103 | 0.054 | 0.103 | Antiadrenergic | |||
| 0.082 | 0.034 | 0.082 | Phosphodiesterase III inhibitor | 0.059 0.053 DBMET02975 | ||
| 0.092 | 0.045 | 0.092 | Neuropeptide Y antagonist | |||
| 0.1 | 0.053 | 0.1 | Adrenaline antagonist | |||
| 0.074 | 0.028 | 0.074 | Nitric oxide donor | 0.07 0.032 DBMET02975 | ||
| 0.05 | 0.007 | 0.05 | Transforming growth factor beta 2 antagonist | 0.038 0.014 DBMET02975 | ||
| 0.057 | 0.015 | 0.09 | Glutamate (mGluR group III) antagonist | 0.09 0.006 DBMET02975 0.049 0.022 DBMET00380 0.045 0.027 DBMET02976 | DBMET02975 | |
| 0.097 | 0.058 | 0.097 | Alpha adrenoreceptor antagonist | |||
| 0.201 | 0.164 | 0.307 | Cholesterol antagonist | 0.297 0.093 DBMET02975 0.277 0.106 DBMET00380 0.307 0.087 DBMET02976 | DBMET02976 | |
| 0.071 | 0.036 | 0.073 | Beta adrenoreceptor antagonist | 0.073 0.035 DBMET02975 | DBMET02975 | |
| 0.147 | 0.113 | 0.187 | Hepatoprotectant | 0.171 0.088 DBMET02975 0.187 0.074 DBMET02976 | DBMET02976 | |
| 0.048 | 0.013 | 0.061 | Glutamate (mGluR8) agonist | 0.061 0.007 DBMET02975 0.048 0.013 DBMET00380 0.052 0.011 DBMET02976 | DBMET02975 | |
| 0.068 | 0.034 | 0.279 | Biliverdin reductase inhibitor | 0.118 0.014 DBMET02975 0.09 0.022 DBMET00380 0.279 0.004 DBMET02976 | DBMET02976 | |
| 0.095 | 0.062 | 0.095 | Pim-1 kinase inhibitor | 0.092 0.065 DBMET02975 | ||
| 0.076 | 0.044 | 0.076 | Potassium channel (Tandem pore domain) blocker | |||
| 0.09 | 0.06 | 0.09 | Potassium channel activator | |||
| 0.129 | 0.102 | 0.185 | Phospholipase A2 inhibitor | 0.185 0.051 DBMET02975 0.12 0.117 DBMET02976 | DBMET02975 | |
| 0.047 | 0.024 | 0.072 | Glutamate (mGluR4) antagonist | 0.072 0.01 DBMET02975 0.044 0.03 DBMET00380 0.049 0.022 DBMET02976 | DBMET02975 | |
| 0.063 | 0.04 | 0.063 | TRPA1 antagonist | |||
| 0.114 | 0.094 | 0.171 | Interleukin 4 antagonist | 0.14 0.06 DBMET02975 0.171 0.034 DBMET00380 | DBMET00380 | |
| 0.104 | 0.084 | 0.104 | Microtubule formation inhibitor | 0.103 0.085 DBMET02976 | ||
| 0.031 | 0.012 | 0.052 | NMDA receptor glycine site antagonist | 0.052 0.005 DBMET02975 0.024 0.018 DBMET02976 | DBMET02975 | |
| 0.084 | 0.065 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | 0.097 0.04 DBMET00380 0.096 0.04 DBMET02976 | DBMET00380 | |
| 0.056 | 0.039 | 0.056 | Beta 1 adrenoreceptor antagonist | 0.054 0.042 DBMET02975 | ||
| 0.092 | 0.075 | 0.278 | GABA C receptor rho-1 antagonist | 0.107 0.053 DBMET02975 0.128 0.034 DBMET00380 0.278 0.004 DBMET02976 | DBMET02976 | |
| 0.061 | 0.045 | 0.11 | NMDA receptor agonist | 0.096 0.021 DBMET02975 0.11 0.016 DBMET02976 | DBMET02976 | |
| 0.171 | 0.155 | 0.251 | Superoxide dismutase inhibitor | 0.213 0.104 DBMET02975 0.222 0.096 DBMET00380 0.251 0.074 DBMET02976 | DBMET02976 | |
| 0.104 | 0.088 | 0.107 | Calcium channel N-type blocker | 0.107 0.083 DBMET00380 | DBMET00380 | |
| 0.079 | 0.063 | 0.081 | Glutathione S-transferase inhibitor | 0.081 0.059 DBMET02975 0.079 0.063 DBMET00380 | DBMET02975 | |
| 0.06 | 0.045 | 0.083 | NMDA receptor glycine site agonist | 0.083 0.026 DBMET02975 0.069 0.038 DBMET02976 | DBMET02975 | |
| 0.14 | 0.125 | 0.14 | Psychostimulant | |||
| 0.089 | 0.075 | 0.229 | UDP-glucose 4-epimerase inhibitor | 0.123 0.041 DBMET02975 0.103 0.057 DBMET00380 0.229 0.015 DBMET02976 | DBMET02976 | |
| 0.072 | 0.059 | 0.102 | GABA aminotransferase inhibitor | 0.102 0.026 DBMET02975 0.097 0.029 DBMET00380 0.088 0.037 DBMET02976 | DBMET02975 | |
| 0.036 | 0.024 | 0.036 | Progesterone antagonist | |||
| 0.08 | 0.07 | 0.083 | 3C-Like protease (SARS coronavirus) inhibitor | 0.083 0.059 DBMET02975 | DBMET02975 | |
| 0.064 | 0.054 | 0.092 | Glutamate (mGluR6) antagonist | 0.078 0.026 DBMET02975 0.092 0.014 DBMET02976 | DBMET02976 | |
| 0.166 | 0.158 | 0.352 | Streptokinase A inhibitor | 0.175 0.15 DBMET02975 0.352 0.061 DBMET00380 | DBMET00380 | |
| 0.025 | 0.017 | 0.034 | Kainate receptor 4 antagonist | 0.034 0.012 DBMET02975 0.026 0.016 DBMET00380 | DBMET02975 | |
| 0.089 | 0.083 | 0.116 | Mediator release inhibitor | 0.116 0.051 DBMET02975 0.102 0.067 DBMET02976 | DBMET02975 | |
| 0.068 | 0.063 | 0.095 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.083 0.049 DBMET02975 0.095 0.04 DBMET00380 | DBMET00380 | |
| 0.047 | 0.043 | 0.047 | Sodium/calcium exchanger inhibitor | |||
| 0.04 | 0.036 | 0.062 | GABA B receptor antagonist | 0.062 0.011 DBMET00380 | DBMET00380 | |
| 0.038 | 0.036 | 0.052 | Kainate receptor agonist | 0.043 0.024 DBMET02975 0.052 0.012 DBMET02976 | DBMET02976 | |
| 0.092 | 0.09 | 0.101 | Factor V inhibitor | 0.101 0.067 DBMET02975 0.098 0.074 DBMET00380 | DBMET02975 | |
| 0.015 | 0.015 | 0.019 | Kainate receptor 3 antagonist | 0.019 0.01 DBMET02975 | DBMET02975 | |
| 0.052 | 0.053 | 0.061 | Androgen agonist | 0.061 0.039 DBMET00380 | DBMET00380 | |
| 0.045 | 0.047 | 0.059 | CD45 antagonist | 0.058 0.023 DBMET02975 0.059 0.023 DBMET00380 | DBMET00380 | |
| 0.062 | 0.065 | 0.45 | Porphobilinogen synthase inhibitor | 0.124 0.027 DBMET02975 0.111 0.031 DBMET00380 0.45 0.004 DBMET02976 | DBMET02976 | |
| 0.023 | 0.026 | 0.045 | NMDA 2D receptor antagonist | 0.045 0.008 DBMET02975 0.03 0.016 DBMET00380 0.026 0.02 DBMET02976 | DBMET02975 | |
| 0.077 | 0.082 | 0.164 | Triose-phosphate isomerase inhibitor | 0.111 0.038 DBMET02975 0.097 0.051 DBMET00380 0.164 0.016 DBMET02976 | DBMET02976 | |
| 0.074 | 0.08 | 0.095 | Thioredoxin reductase inhibitor | 0.076 0.075 DBMET02975 0.095 0.033 DBMET00380 | DBMET00380 | |
| 0.09 | 0.096 | 0.27 | GABA C receptor antagonist | 0.1 0.078 DBMET02975 0.101 0.076 DBMET00380 0.27 0.005 DBMET02976 | DBMET02976 | |
| 0.048 | 0.056 | 0.096 | Dihydroorotate oxidase inhibitor | 0.061 0.028 DBMET02975 0.096 0.005 DBMET02976 | DBMET02976 | |
| 0.143 | 0.152 | 0.294 | Histone acetyltransferase inhibitor | 0.294 0.015 DBMET00380 | DBMET00380 | |
| 0.014 | 0.024 | 0.028 | Kainate receptor 5 antagonist | 0.028 0.01 DBMET02975 | DBMET02975 | |
| 0.057 | 0.067 | 0.077 | Transcription factor RelA inhibitor | 0.077 0.02 DBMET00380 | DBMET00380 | |
| 0.034 | 0.044 | 0.147 | Phosphorylase inhibitor | 0.07 0.02 DBMET02975 0.147 0.007 DBMET02976 | DBMET02976 | |
| 0.032 | 0.044 | 0.1 | Glutamate (mGluR1a) antagonist | 0.1 0.005 DBMET02976 | DBMET02976 | |
| 0.026 | 0.038 | 0.041 | Catechol O-methyltransferase inhibitor | 0.041 0.013 DBMET00380 | DBMET00380 | |
| 0.036 | 0.049 | 0.065 | Thromboxane A2 antagonist | 0.065 0.025 DBMET02975 | DBMET02975 | |
| 0.036 | 0.049 | 0.046 | AICAR transformylase inhibitor | 0.042 0.035 DBMET02975 0.046 0.027 DBMET00380 0.045 0.028 DBMET02976 | DBMET00380 | |
| 0.096 | 0.109 | 0.143 | M17 leucyl aminopeptidase inhibitor | 0.143 0.06 DBMET02975 0.13 0.069 DBMET00380 | DBMET02975 | |
| 0.04 | 0.054 | 0.069 | Thromboxane antagonist | 0.069 0.027 DBMET02975 | DBMET02975 | |
| 0.043 | 0.057 | 0.255 | Alcohol oxidase inhibitor | 0.085 0.022 DBMET02975 0.067 0.03 DBMET00380 0.255 0.005 DBMET02976 | DBMET02976 | |
| 0.075 | 0.09 | 0.249 | Breast cancer-resistant protein inhibitor | 0.249 0.009 DBMET00380 | DBMET00380 | |
| 0.067 | 0.082 | 0.08 | GABA B receptor agonist | 0.074 0.056 DBMET02975 0.08 0.041 DBMET02976 | DBMET02976 | |
| 0.134 | 0.149 | 0.141 | Death-associated protein kinase 2 inhibitor | 0.141 0.13 DBMET02976 | DBMET02976 | |
| 0.1 | 0.116 | 0.163 | Alkaline phosphatase inhibitor | 0.163 0.052 DBMET00380 | DBMET00380 | |
| 0.167 | 0.184 | 0.185 | Transcription factor STAT3 inhibitor | 0.182 0.161 DBMET02975 0.185 0.156 DBMET00380 | DBMET00380 | |
| 0.172 | 0.191 | 0.246 | Gastrin inhibitor | 0.198 0.153 DBMET02975 0.246 0.084 DBMET02976 | DBMET02976 | |
| 0.128 | 0.147 | 0.18 | ATPase inhibitor | 0.18 0.058 DBMET02976 | DBMET02976 | |
| 0.204 | 0.224 | 0.474 | Antibacterial | 0.312 0.126 DBMET02975 0.248 0.179 DBMET00380 0.474 0.048 DBMET02976 | DBMET02976 | |
| 0.126 | 0.146 | 0.174 | Ca2+-transporting ATPase inhibitor | 0.135 0.093 DBMET02975 0.174 0.01 DBMET02976 | DBMET02976 | |
| 0.256 | 0.277 | 0.525 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.306 0.205 DBMET00380 0.525 0.024 DBMET02976 | DBMET02976 | |
| 0.164 | 0.188 | 0.396 | Prostaglandin dehydrogenase inhibitor | 0.396 0.068 DBMET00380 | DBMET00380 | |
| 0.072 | 0.097 | 0.087 | D-Ala-D-Ala ligase inhibitor | 0.083 0.06 DBMET02975 0.086 0.052 DBMET00380 0.087 0.05 DBMET02976 | DBMET02976 | |
| 0.094 | 0.12 | 0.103 | Cathepsin H inhibitor | 0.103 0.101 DBMET00380 | DBMET00380 | |
| 0.082 | 0.109 | 0.133 | Interleukin 1b antagonist | 0.133 0.053 DBMET00380 | DBMET00380 | |
| 0.024 | 0.051 | 0.054 | Kainate receptor antagonist | 0.054 0.019 DBMET02975 | DBMET02975 | |
| 0.137 | 0.165 | 0.161 | Free radical scavenger | 0.161 0.133 DBMET02975 | DBMET02975 | |
| 0.154 | 0.183 | 0.212 | Peptidyltransferase inhibitor | 0.18 0.128 DBMET02975 0.212 0.085 DBMET02976 | DBMET02976 | |
| 0.117 | 0.149 | 0.198 | DNA methyltransferase I inhibitor | 0.161 0.094 DBMET02975 0.198 0.07 DBMET00380 | DBMET00380 | |
| 0.051 | 0.084 | 0.071 | Interferon inducer | 0.071 0.034 DBMET00380 | DBMET00380 | |
| 0.072 | 0.105 | 0.084 | Thioredoxin inhibitor | 0.084 0.073 DBMET00380 | DBMET00380 | |
| 0.157 | 0.19 | 0.3 | DNA synthesis inhibitor | 0.217 0.098 DBMET02975 0.3 0.043 DBMET02976 | DBMET02976 | |
| 0.049 | 0.084 | 0.07 | Ryanodine receptor antagonist | 0.057 0.046 DBMET00380 0.07 0.018 DBMET02976 | DBMET02976 | |
| 0.05 | 0.085 | 0.06 | Bcl-xL inhibitor | 0.06 0.04 DBMET00380 | DBMET00380 | |
| 0.057 | 0.096 | 0.063 | MDM2 inhibitor | 0.063 0.061 DBMET00380 | DBMET00380 | |
| 0.045 | 0.084 | 0.068 | DNA gyrase inhibitor | 0.068 0.038 DBMET02975 | DBMET02975 | |
| 0.087 | 0.127 | 0.108 | Cyclooxygenase 3 inhibitor | 0.108 0.092 DBMET02976 | DBMET02976 | |
| 0.167 | 0.208 | 0.258 | Tyrosine 3 hydroxylase inhibitor | 0.258 0.061 DBMET02976 | DBMET02976 | |
| 0.105 | 0.149 | 0.17 | Arachidonic acid antagonist | 0.17 0.065 DBMET02976 | DBMET02976 | |
| 0.03 | 0.076 | 0.059 | Dihydroorotate dehydrogenase inhibitor | 0.059 0.029 DBMET02975 0.055 0.033 DBMET00380 0.051 0.036 DBMET02976 | DBMET02975 | |
| 0.034 | 0.08 | 0.133 | Argininosuccinate synthase inhibitor | 0.054 0.043 DBMET02975 0.133 0.013 DBMET02976 | DBMET02976 | |
| 0.067 | 0.115 | 0.092 | Interleukin 5 antagonist | 0.092 0.052 DBMET00380 | DBMET00380 | |
| 0.072 | 0.121 | 0.099 | Xanthine oxidase inhibitor | 0.099 0.061 DBMET02975 0.091 0.069 DBMET00380 0.092 0.068 DBMET02976 | DBMET02975 | |
| 0.011 | 0.061 | 0.023 | Kynurenine 3 monooxygenase inhibitor | 0.023 0.022 DBMET00380 | DBMET00380 | |
| 0.028 | 0.078 | 0.051 | Nerve growth factor antagonist | 0.051 0.017 DBMET00380 0.044 0.028 DBMET02976 | DBMET00380 | |
| 0.077 | 0.127 | 0.104 | Amylase inhibitor | 0.104 0.093 DBMET02976 | DBMET02976 | |
| 0.072 | 0.124 | 0.288 | Anesthetic local | 0.288 0.014 DBMET00380 | DBMET00380 | |
| 0.012 | 0.065 | 0.028 | AMPA 2 receptor antagonist | 0.028 0.022 DBMET00380 | DBMET00380 | |
| 0.055 | 0.112 | 0.082 | Interferon agonist | 0.082 0.05 DBMET00380 | DBMET00380 | |
| 0.218 | 0.276 | 0.523 | 5 Hydroxytryptamine release inhibitor | 0.293 0.173 DBMET02975 0.29 0.176 DBMET00380 0.523 0.026 DBMET02976 | DBMET02976 | |
| 0.068 | 0.127 | 0.104 | Anabolic | 0.104 0.056 DBMET02976 | DBMET02976 | |
| 0.015 | 0.076 | 0.06 | Nicotinic acid receptor agonist | 0.037 0.024 DBMET02975 0.06 0.011 DBMET02976 | DBMET02976 | |
| 0.1 | 0.162 | 0.163 | NOS3 expression enhancer | 0.163 0.061 DBMET02976 | DBMET02976 | |
| 0.026 | 0.088 | 0.066 | Dihydroorotase inhibitor | 0.041 0.036 DBMET02975 0.066 0.013 DBMET02976 | DBMET02976 | |
| 0.065 | 0.129 | 0.389 | Ferrochelatase inhibitor | 0.105 0.066 DBMET02975 0.389 0.004 DBMET02976 | DBMET02976 | |
| 0.042 | 0.106 | 0.082 | Na+ K+ transporting ATPase inhibitor | 0.082 0.049 DBMET00380 | DBMET00380 | |
| 0.098 | 0.164 | 0.219 | Dual specificity phosphatase 3 inhibitor | 0.156 0.092 DBMET02975 0.219 0.051 DBMET00380 | DBMET00380 | |
| 0.042 | 0.109 | 0.064 | Pregnane X receptor antagonist | 0.064 0.023 DBMET02976 | DBMET02976 | |
| 0.024 | 0.094 | 0.036 | AMPA 4 receptor antagonist | 0.036 0.035 DBMET02976 | DBMET02976 | |
| 0.021 | 0.091 | 0.052 | Angiotensin AT1 receptor antagonist | 0.052 0.014 DBMET00380 | DBMET00380 | |
| 0.039 | 0.11 | 0.099 | Purinergic P2X1 antagonist | 0.073 0.03 DBMET00380 0.099 0.017 DBMET02976 | DBMET02976 | |
| 0.069 | 0.142 | 0.092 | Glutamate release inhibitor | 0.092 0.056 DBMET02976 | DBMET02976 | |
| 0.047 | 0.12 | 0.228 | Glutamate dehydrogenase inhibitor | 0.068 0.06 DBMET02975 0.228 0.008 DBMET02976 | DBMET02976 | |
| 0.042 | 0.117 | 0.077 | Bcl2 antagonist | 0.077 0.034 DBMET00380 | DBMET00380 | |
| 0.028 | 0.103 | 0.056 | GABA A receptor antagonist | 0.056 0.034 DBMET00380 | DBMET00380 | |
| 0.033 | 0.109 | 0.136 | Phosphofructokinase-1 inhibitor | 0.136 0.021 DBMET02976 | DBMET02976 | |
| 0.014 | 0.092 | 0.043 | Fumarate hydratase inhibitor | 0.043 0.017 DBMET02976 | DBMET02976 | |
| 0.063 | 0.144 | 0.106 | Carbonic anhydrase III inhibitor | 0.106 0.056 DBMET02976 | DBMET02976 | |
| 0.034 | 0.116 | 0.071 | Sphingosine 1-phosphate receptor 4 agonist | 0.071 0.044 DBMET00380 0.063 0.051 DBMET02976 | DBMET00380 | |
| 0.08 | 0.162 | 0.213 | Toll-Like receptor antagonist | 0.213 0.026 DBMET00380 | DBMET00380 | |
| 0.018 | 0.101 | 0.039 | Angiotensin II receptor antagonist | 0.039 0.015 DBMET00380 | DBMET00380 | |
| 0.05 | 0.134 | 0.115 | Keratolytic | 0.069 0.068 DBMET02975 0.115 0.023 DBMET02976 | DBMET02976 | |
| 0.137 | 0.221 | 0.278 | Thyroid hormone beta antagonist | 0.278 0.1 DBMET00380 | DBMET00380 | |
| 0.055 | 0.14 | 0.083 | HIV-1 integrase (Overall Integration) inhibitor | 0.083 0.073 DBMET02976 | DBMET02976 | |
| 0.096 | 0.182 | 0.144 | Heat shock protein 90 alpha antagonist | 0.144 0.093 DBMET00380 | DBMET00380 | |
| 0.077 | 0.163 | 0.167 | Toll-Like receptor 9 antagonist | 0.167 0.053 DBMET00380 | DBMET00380 | |
| 0.137 | 0.225 | 0.287 | Thyroid hormone antagonist | 0.287 0.1 DBMET00380 | DBMET00380 | |
| 0.027 | 0.115 | 0.053 | GABA receptor antagonist | 0.053 0.04 DBMET00380 | DBMET00380 | |
| 0.018 | 0.108 | 0.06 | AMPA receptor antagonist | 0.06 0.025 DBMET00380 | DBMET00380 | |
| 0.161 | 0.252 | 0.293 | 5 Hydroxytryptamine uptake stimulant | 0.293 0.049 DBMET02976 | DBMET02976 | |
| 0.097 | 0.19 | 0.177 | Dual specificity phosphatase inhibitor | 0.143 0.102 DBMET02975 0.177 0.069 DBMET00380 | DBMET00380 | |
| 0.089 | 0.184 | 0.157 | Hexokinase inhibitor | 0.136 0.095 DBMET02975 0.157 0.071 DBMET00380 0.128 0.106 DBMET02976 | DBMET00380 | |
| 0.026 | 0.121 | 0.07 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.07 0.005 DBMET02976 | DBMET02976 | |
| 0.048 | 0.145 | 0.078 | Calcium channel P-type blocker | 0.078 0.017 DBMET00380 | DBMET00380 | |
| 0.011 | 0.108 | 0.044 | Nicotinic acid receptor 2 antagonist | 0.044 0.004 DBMET02976 | DBMET02976 | |
| 0.056 | 0.156 | 0.542 | GABA C receptor agonist | 0.094 0.074 DBMET02975 0.542 0.003 DBMET02976 | DBMET02976 | |
| 0.108 | 0.208 | 0.162 | Focal adhesion kinase 2 inhibitor | 0.162 0.111 DBMET02976 | DBMET02976 | |
| 0.047 | 0.148 | 0.13 | Aminopeptidase B inhibitor | 0.13 0.047 DBMET02976 | DBMET02976 | |
| 0.078 | 0.18 | 0.204 | Interleukin 1 antagonist | 0.204 0.031 DBMET00380 | DBMET00380 | |
| 0.027 | 0.129 | 0.126 | Aconitate hydratase inhibitor | 0.126 0.005 DBMET02976 | DBMET02976 | |
| 0.189 | 0.291 | 0.326 | Apoptosis agonist | 0.326 0.155 DBMET00380 | DBMET00380 | |
| 0.121 | 0.224 | 0.356 | DNA damaging | 0.356 0.039 DBMET00380 0.2 0.115 DBMET02976 | DBMET00380 | |
| 0.042 | 0.145 | 0.097 | Ornithine decarboxylase inhibitor | 0.097 0.047 DBMET02976 | DBMET02976 | |
| 0.064 | 0.167 | 0.105 | Carbonic anhydrase XV inhibitor | 0.105 0.061 DBMET02976 | DBMET02976 | |
| 0.013 | 0.119 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.019 DBMET02976 | DBMET02976 | |
| 0.016 | 0.123 | 0.04 | Guanylate cyclase inhibitor | 0.04 0.033 DBMET02976 | DBMET02976 | |
| 0.017 | 0.125 | 0.064 | Ornithine carbamoyltransferase inhibitor | 0.064 0.029 DBMET02976 | DBMET02976 | |
| 0.018 | 0.133 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET02976 | DBMET02976 | |
| 0.029 | 0.147 | 0.074 | Catalase inhibitor | 0.074 0.051 DBMET02976 | DBMET02976 | |
| 0.108 | 0.227 | 0.149 | Phospholipase C inhibitor | 0.149 0.108 DBMET02976 | DBMET02976 | |
| 0.039 | 0.158 | 0.063 | Glutamate (mGluR7) antagonist | 0.063 0.056 DBMET02976 | DBMET02976 | |
| 0.018 | 0.137 | 0.105 | Xanthine dehydrogenase inhibitor | 0.105 0.014 DBMET02976 | DBMET02976 | |
| 0.154 | 0.277 | 0.426 | Histamine release inhibitor | 0.245 0.159 DBMET02975 0.222 0.179 DBMET00380 0.426 0.062 DBMET02976 | DBMET02976 | |
| 0.043 | 0.167 | 0.075 | Carbonic anhydrase VI inhibitor | 0.075 0.064 DBMET02976 | DBMET02976 | |
| 0.021 | 0.145 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 DBMET02976 | DBMET02976 | |
| 0.148 | 0.272 | 0.276 | Sodium/bile acid cotransporter inhibitor | 0.245 0.133 DBMET02975 0.207 0.179 DBMET00380 0.276 0.101 DBMET02976 | DBMET02976 | |
| 0.078 | 0.203 | 0.308 | Cell wall synthesis inhibitor | 0.308 0.009 DBMET02976 | DBMET02976 | |
| 0.09 | 0.219 | 0.154 | DNA methylase inhibitor | 0.154 0.114 DBMET00380 | DBMET00380 | |
| 0.007 | 0.136 | 0.045 | Uridine phosphorylase inhibitor | 0.045 0.01 DBMET02976 | DBMET02976 | |
| 0.047 | 0.179 | 0.152 | Creatine kinase inhibitor | 0.152 0.023 DBMET02976 | DBMET02976 | |
| 0.036 | 0.17 | 0.069 | Adenine nucleotide translocase inhibitor | 0.06 0.029 DBMET02975 0.069 0.017 DBMET02976 | DBMET02976 | |
| 0.039 | 0.173 | 0.102 | Histamine N-methyltransferase inhibitor | 0.102 0.044 DBMET02976 | DBMET02976 | |
| 0.061 | 0.195 | 0.433 | Alpha-N-acetylglucosaminidase inhibitor | 0.101 0.1 DBMET02975 0.433 0.007 DBMET02976 | DBMET02976 | |
| 0.065 | 0.199 | 0.264 | Aldehyde dehydrogenase inhibitor | 0.264 0.016 DBMET02976 | DBMET02976 | |
| 0.01 | 0.149 | 0.024 | Retinoic acid gamma receptor agonist | 0.024 0.013 DBMET02976 | DBMET02976 | |
| 0.052 | 0.191 | 0.21 | Glutamate receptor antagonist | 0.21 0.023 DBMET00380 | DBMET00380 | |
| 0.093 | 0.233 | 0.144 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.071 DBMET02976 | DBMET02976 | |
| 0.065 | 0.206 | 0.13 | NADPH oxidase inhibitor | 0.13 0.071 DBMET00380 | DBMET00380 | |
| 0.009 | 0.151 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.016 DBMET02976 | DBMET02976 | |
| 0.069 | 0.211 | 0.33 | Peroxidase inhibitor | 0.33 0.032 DBMET02976 | DBMET02976 | |
| 0.035 | 0.179 | 0.084 | Potassium channel (Ca-activated) activator | 0.078 0.077 DBMET00380 0.084 0.07 DBMET02976 | DBMET02976 | |
| 0.041 | 0.185 | 0.081 | Glycine receptor agonist | 0.081 0.038 DBMET02976 | DBMET02976 | |
| 0.048 | 0.194 | 0.124 | Cystathionine beta-synthase inhibitor | 0.124 0.055 DBMET02976 | DBMET02976 | |
| 0.005 | 0.152 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.028 0.005 DBMET02976 | DBMET02976 | |
| 0.053 | 0.201 | 0.098 | Protein kinase C gamma inhibitor | 0.098 0.08 DBMET02976 | DBMET02976 | |
| 0.016 | 0.164 | 0.053 | Retinoic acid alpha receptor agonist | 0.037 0.03 DBMET02975 0.053 0.012 DBMET02976 | DBMET02976 | |
| 0.011 | 0.162 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 DBMET02976 | DBMET02976 | |
| 0.073 | 0.225 | 0.334 | Pyruvate kinase inhibitor | 0.334 0.039 DBMET00380 | DBMET00380 | |
| 0.014 | 0.167 | 0.039 | Glutamate (mGluR3) antagonist | 0.039 0.022 DBMET02976 | DBMET02976 | |
| 0.028 | 0.183 | 0.113 | Glutamate decarboxylase inhibitor | 0.113 0.023 DBMET02976 | DBMET02976 | |
| 0.08 | 0.236 | 0.107 | DNA repair enzyme inhibitor | 0.107 0.104 DBMET00380 | DBMET00380 | |
| 0.055 | 0.212 | 0.168 | Lipid peroxidase inhibitor | 0.168 0.057 DBMET02976 | DBMET02976 | |
| 0.01 | 0.17 | 0.04 | Retinoid X alpha receptor agonist | 0.04 0.019 DBMET02976 | DBMET02976 | |
| 0.01 | 0.171 | 0.05 | Nicotinic acid receptor 2 agonist | 0.05 0.014 DBMET02976 | DBMET02976 | |
| 0.013 | 0.176 | 0.042 | GABA uptake inhibitor | 0.042 0.024 DBMET02976 | DBMET02976 | |
| 0.017 | 0.185 | 0.073 | HIV-1 integrase (Strand Transfer) inhibitor | 0.073 0.034 DBMET02976 | DBMET02976 | |
| 0.048 | 0.216 | 0.143 | NADH dehydrogenase inhibitor | 0.143 0.019 DBMET02976 | DBMET02976 | |
| 0.045 | 0.215 | 0.091 | 5 Hydroxytryptamine 3A agonist | 0.091 0.087 DBMET02976 | DBMET02976 | |
| 0.17 | 0.341 | 0.272 | MAP kinase 1 inhibitor | 0.272 0.21 DBMET00380 | DBMET00380 | |
| 0.008 | 0.18 | 0.022 | Retinoid X beta receptor antagonist | 0.022 0.012 DBMET02976 | DBMET02976 | |
| 0.033 | 0.206 | 0.074 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.074 0.05 DBMET00380 | DBMET00380 | |
| 0.015 | 0.188 | 0.061 | Neuraminidase inhibitor | 0.061 0.043 DBMET02976 | DBMET02976 | |
| 0.008 | 0.183 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.012 DBMET02976 | DBMET02976 | |
| 0.03 | 0.21 | 0.097 | Glutamate (mGluR group I) antagonist | 0.097 0.027 DBMET00380 | DBMET00380 | |
| 0.007 | 0.187 | 0.035 | Retinoid X receptor agonist | 0.035 0.025 DBMET02976 | DBMET02976 | |
| 0.102 | 0.284 | 0.139 | Catenin beta inhibitor | 0.139 0.133 DBMET00380 | DBMET00380 | |
| 0.014 | 0.198 | 0.045 | Membrane dipeptidase inhibitor | 0.045 0.02 DBMET02976 | DBMET02976 | |
| 0.123 | 0.308 | 0.26 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.26 0.098 DBMET02976 | DBMET02976 | |
| 0.008 | 0.194 | 0.022 | Retinoic acid receptor agonist | 0.022 0.019 DBMET02976 | DBMET02976 | |
| 0.024 | 0.213 | 0.05 | Heparanase inhibitor | 0.05 0.046 DBMET02976 | DBMET02976 | |
| 0.005 | 0.197 | 0.02 | Retinoic acid alpha receptor antagonist | 0.02 0.014 DBMET02976 | DBMET02976 | |
| 0.014 | 0.207 | 0.043 | Adenosine deaminase inhibitor | 0.043 0.037 DBMET02976 | DBMET02976 | |
| 0.024 | 0.218 | 0.097 | Topoisomerase II beta inhibitor | 0.097 0.01 DBMET02976 | DBMET02976 | |
| 0.038 | 0.233 | 0.151 | Glycogen synthase kinase-3 alpha inhibitor | 0.151 0.066 DBMET00380 | DBMET00380 | |
| 0.021 | 0.224 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.042 DBMET02976 | DBMET02976 | |
| 0.025 | 0.231 | 0.088 | Monophenol monooxygenase inhibitor | 0.088 0.085 DBMET02976 | DBMET02976 | |
| 0.005 | 0.212 | 0.029 | Retinoid X gamma receptor agonist | 0.029 0.011 DBMET02976 | DBMET02976 | |
| 0.005 | 0.215 | 0.024 | Retinoid X beta receptor agonist | 0.024 0.012 DBMET02976 | DBMET02976 | |
| 0.015 | 0.228 | 0.034 | Retinoid X alpha receptor antagonist | 0.034 0.023 DBMET02976 | DBMET02976 | |
| 0.003 | 0.22 | 0.011 | Retinoic acid beta receptor antagonist | 0.011 0.01 DBMET02976 | DBMET02976 | |
| 0.005 | 0.222 | 0.017 | Retinoic acid receptor antagonist | 0.017 0.015 DBMET02976 | DBMET02976 | |
| 0.097 | 0.314 | 0.128 | CC chemokine 6 receptor antagonist | 0.12 0.116 DBMET00380 0.128 0.078 DBMET02976 | DBMET02976 | |
| 0.016 | 0.234 | 0.038 | Retinoid X receptor antagonist | 0.038 0.026 DBMET02976 | DBMET02976 | |
| 0.073 | 0.293 | 0.129 | Adenylate cyclase stimulant | 0.129 0.103 DBMET02976 | DBMET02976 | |
| 0.02 | 0.241 | 0.069 | Neuraminidase (influenza) inhibitor | 0.069 0.036 DBMET02976 | DBMET02976 | |
| 0.091 | 0.312 | 0.22 | Lipoxygenase inhibitor | 0.22 0.121 DBMET00380 | DBMET00380 | |
| 0.047 | 0.272 | 0.124 | Protein-tyrosine phosphatase inhibitor | 0.124 0.109 DBMET02975 | DBMET02975 | |
| 0.043 | 0.272 | 0.139 | Electrolyte absorption antagonist | 0.139 0.024 DBMET02976 | DBMET02976 | |
| 0.035 | 0.264 | 0.087 | Prolactin inhibitor | 0.087 0.071 DBMET02976 | DBMET02976 | |
| 0.099 | 0.329 | 0.216 | 5 Hydroxytryptamine release stimulant | 0.216 0.109 DBMET02976 | DBMET02976 | |
| 0.064 | 0.296 | 0.183 | MAP kinase kinase 2 inhibitor | 0.183 0.093 DBMET02976 | DBMET02976 | |
| 0.114 | 0.348 | 0.248 | Insulysin inhibitor | 0.248 0.098 DBMET02976 | DBMET02976 | |
| 0.017 | 0.258 | 0.037 | Glutamate (mGluR8) antagonist | 0.037 0.022 DBMET02976 | DBMET02976 | |
| 0.065 | 0.312 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.109 DBMET02976 | DBMET02976 | |
| 0.016 | 0.267 | 0.059 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.036 DBMET02976 | DBMET02976 | |
| 0.024 | 0.275 | 0.107 | Glutamate (mGluR) antagonist | 0.107 0.031 DBMET00380 | DBMET00380 | |
| 0.046 | 0.305 | 0.11 | Antibacterial (Helicobacter pylori) | 0.11 0.098 DBMET00380 | DBMET00380 | |
| 0.012 | 0.274 | 0.074 | Acyl-CoA dehydrogenase inhibitor | 0.074 0.025 DBMET02976 | DBMET02976 | |
| 0.06 | 0.327 | 0.345 | Aldehyde oxidase inhibitor | 0.345 0.056 DBMET02976 | DBMET02976 | |
| 0.025 | 0.293 | 0.191 | Alcohol dehydrogenase inhibitor | 0.191 0.013 DBMET02976 | DBMET02976 | |
| 0.121 | 0.39 | 0.17 | 5 Hydroxytryptamine 3E antagonist | 0.17 0.136 DBMET02976 | DBMET02976 | |
| 0.044 | 0.314 | 0.267 | Electron transport complex I inhibitor | 0.267 0.005 DBMET02976 | DBMET02976 | |
| 0.021 | 0.29 | 0.096 | Aminopeptidase I inhibitor | 0.096 0.03 DBMET02976 | DBMET02976 | |
| 0.034 | 0.304 | 0.097 | Mucolytic | 0.097 0.082 DBMET02976 | DBMET02976 | |
| 0.007 | 0.291 | 0.026 | Retinoid X gamma receptor antagonist | 0.026 0.02 DBMET02976 | DBMET02976 | |
| 0.036 | 0.336 | 0.084 | MAP kinase kinase 7 inhibitor | 0.084 0.037 DBMET02976 | DBMET02976 | |
| 0.042 | 0.346 | 0.114 | Cytokine production inhibitor | 0.114 0.096 DBMET00380 | DBMET00380 | |
| 0.015 | 0.321 | 0.124 | Phenylalanine 4-hydroxylase inhibitor | 0.124 0.017 DBMET02976 | DBMET02976 | |
| 0.012 | 0.32 | 0.063 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 DBMET02976 | DBMET02976 | |
| 0.048 | 0.358 | 0.157 | Histone deacetylase SIRT1 inhibitor | 0.157 0.056 DBMET02976 | DBMET02976 | |
| 0.012 | 0.335 | 0.031 | Protein kinase (CK2) beta inhibitor | 0.031 0.03 DBMET02976 | DBMET02976 | |
| 0.016 | 0.349 | 0.058 | Dopamine beta hydroxylase inhibitor | 0.058 0.018 DBMET02976 | DBMET02976 | |
| 0.042 | 0.385 | 0.154 | Death-associated protein kinase 3 inhibitor | 0.154 0.116 DBMET02976 | DBMET02976 | |
| 0.004 | 0.352 | 0.04 | Geranyltranstransferase inhibitor | 0.04 0.037 DBMET02976 | DBMET02976 | |
| 0.046 | 0.402 | 0.163 | Platelet adhesion inhibitor | 0.163 0.093 DBMET00380 | DBMET00380 | |
| 0.026 | 0.387 | 0.101 | Chelator | 0.101 0.075 DBMET02976 | DBMET02976 | |
| 0.002 | 0.375 | 0.011 | Egl nine homolog 3 inhibitor | 0.011 0.01 DBMET02976 | DBMET02976 | |
| 0.007 | 0.383 | 0.028 | Purinergic P2Y14 antagonist | 0.028 0.024 DBMET02976 | DBMET02976 | |
| 0.024 | 0.419 | 0.102 | Uric acid excretion stimulant | 0.102 0.051 DBMET02976 | DBMET02976 | |
| 0.015 | 0.412 | 0.078 | Phospholipase D inhibitor | 0.078 0.038 DBMET02976 | DBMET02976 | |
| 0.028 | 0.434 | 0.225 | I kappa B kinase epsilon inhibitor | 0.225 0.052 DBMET02976 | DBMET02976 | |
| 0.012 | 0.445 | 0.096 | 5-Lipoxygenase inhibitor | 0.096 0.067 DBMET00380 | DBMET00380 | |
| 0.019 | 0.453 | 0.047 | Factor III inhibitor | 0.047 0.044 DBMET02976 | DBMET02976 | |
| 0.033 | 0.468 | 0.145 | Antimitotic | 0.145 0.126 DBMET02976 | DBMET02976 | |
| 0.021 | 0.461 | 0.105 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.105 0.034 DBMET02976 | DBMET02976 | |
| 0.005 | 0.448 | 0.068 | Prostaglandin EP2 antagonist | 0.068 0.035 DBMET02976 | DBMET02976 | |
| 0.019 | 0.469 | 0.114 | ATPase (Vacuolar H+) inhibitor | 0.114 0.024 DBMET02976 | DBMET02976 | |
| 0.106 | 0.567 | 0.183 | MAP kinase kinase 3 inhibitor | 0.183 0.179 DBMET02976 | DBMET02976 | |
| 0.023 | 0.499 | 0.066 | Kallikrein 7 inhibitor | 0.066 0.038 DBMET02976 | DBMET02976 | |
| 0.02 | 0.515 | 0.081 | Viral attachment inhibitor | 0.081 0.047 DBMET00380 | DBMET00380 | |
| 0.029 | 0.584 | 0.118 | Aurora-C kinase inhibitor | 0.118 0.112 DBMET02976 | DBMET02976 | |
| 0.035 | 0.777 | 0.129 | MAP kinase kinase 4 inhibitor | 0.129 0.117 DBMET02976 | DBMET02976 | |
| 0.014 | 0.81 | 0.186 | EphB2 antagonist | 0.186 0.098 DBMET02976 | DBMET02976 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |